Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionDnB Asset Management AS
Latest Disclosed Ownership273,107 shares
Latest Disclosed Value $ 38,062,923
DnB Asset Management AS reports 7.34% increase in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - DnB Asset Management AS filed a 13F-HR form disclosing ownership of 273,107 shares of Gilead Sciences, Inc. (CH:GILD) valued at $38,062,923 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 254,443 shares of Gilead Sciences, Inc.. This represents a change in shares of 7.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Gilead Sciences COM 375558103 273,107 18,664 7.34 38,063 21.88 0.1357
2026-02-05 2025-12-31 13F Gilead Sciences COM 375558103 254,443 9,326 3.80 31,230 14.79 0.1090
2025-11-12 2025-09-30 13F Gilead Sciences COM 375558103 245,117 -44,223 -15.28 27,208 -15.19 0.1017
2025-08-12 2025-06-30 13F Gilead Sciences COM 375558103 289,340 61,277 26.87 32,079 25.53 0.1330
2025-05-15 2025-03-31 13F Gilead Sciences common 375558103 228,063 -75,040 -24.76 25,554 -8.73 0.1178
2025-02-12 2024-12-31 13F Gilead Sciences COM 375558103 303,103 14,626 5.07 27,998 15.76 0.1211
2024-11-12 2024-09-30 13F Gilead Sciences COM 375558103 288,477 -2,326 -0.80 24,186 21.22 0.1092
2024-07-05 2024-06-30 13F Gilead Sciences common 375558103 290,803 93,165 47.14 19,952 37.82 0.0952
2024-04-12 2024-03-31 13F Gilead Sciences common 375558103 197,638 -53,988 -21.46 14,477 -28.98 0.0755
2024-01-04 2023-12-31 13F Gilead Sciences common 375558103 251,626 -58,703 -18.92 20,384 -12.35 0.1058
2023-10-13 2023-09-30 13F Gilead Sciences common 375558103 310,329 2,417 0.78 23,256 -2.00 0.1389
2023-07-10 2023-06-30 13F/A-1 Gilead Sciences common 375558103 307,912 -7,725 -2.45 23,731 -9.39 0.1364
2023-07-06 2023-06-30 13F Gilead Sciences common 375558103 307,912 -7,725 23,731 0.1396
2023-04-20 2023-03-31 13F Gilead Sciences common 375558103 315,637 -6,567 -2.04 26,188 -5.33 0.1660
2023-01-12 2022-12-31 13F Gilead Sciences common 375558103 322,204 -5,010 -1.53 27,661 37.04 0.1950
2022-10-11 2022-09-30 13F Gilead Sciences common 375558103 327,214 -57,724 -15.00 20,186 -15.16 0.1557
2022-07-08 2022-06-30 13F Gilead Sciences common 375558103 384,938 -20,854 -5.14 23,793 -1.37 0.1673
2022-04-08 2022-03-31 13F Gilead Sciences common 375558103 405,792 58,670 16.90 24,124 -4.29 0.1434
2022-01-12 2021-12-31 13F Gilead Sciences common 375558103 347,122 30,308 9.57 25,205 13.90 0.1479
2021-10-15 2021-09-30 13F Gilead Sciences common 375558103 316,814 -651 -0.21 22,129 1.23 0.1437
2021-07-06 2021-06-30 13F Gilead Sciences common 375558103 317,465 7,116 2.29 21,861 8.99 0.1448
2021-04-15 2021-03-31 13F Gilead Sciences common 375558103 310,349 -1,223,144 -79.76 20,058 -77.55 0.1464
2021-01-19 2020-12-31 13F Gilead Sciences common 375558103 1,533,493 -288,155 -15.82 89,341 -22.39 0.7829
2020-10-14 2020-09-30 13F Gilead Sciences common 375558103 1,821,648 1,481,374 435.35 115,110 339.68 1.2236
2020-07-08 2020-06-30 13F Gilead Sciences common 375558103 340,274 59,282 21.10 26,181 24.63 0.3075
2020-04-17 2020-03-31 13F Gilead Sciences common 375558103 280,992 108,091 62.52 21,007 86.97 0.3090
2020-01-13 2019-12-31 13F Gilead Sciences common 375558103 172,901 -55,705 -24.37 11,235 -22.46 0.1104
2019-10-16 2019-09-30 13F Gilead Sciences common 375558103 228,606 -87,820 -27.75 14,489 -32.22 0.1635
2019-07-08 2019-06-30 13F Gilead Sciences common 375558103 316,426 25,719 8.85 21,378 13.12 0.2462
2019-04-11 2019-03-31 13F Gilead Sciences common 375558103 290,707 -30,086 -9.38 18,899 -5.82 0.2154
2019-01-15 2018-12-31 13F Gilead Sciences common 375558103 320,793 33,981 11.85 20,066 -9.39 0.2602
2018-10-10 2018-09-30 13F Gilead Sciences common 375558103 286,812 130,260 83.21 22,145 99.68 0.2489
2018-07-06 2018-06-30 13F Gilead Sciences common 375558103 156,552 6,600 4.40 11,090 -1.89 0.1309
2018-04-11 2018-03-31 13F Gilead Sciences common 375558103 149,952 13,100 9.57 11,305 15.30 0.1361
2018-01-10 2017-12-31 13F Gilead Sciences common 375558103 136,852 2,370 1.76 9,804 -10.01 0.1182
2017-10-11 2017-09-30 13F Gilead Sciences common 375558103 134,482 -115,900 -46.29 10,896 -38.52 0.1449
2017-07-06 2017-06-30 13F Gilead Sciences common 375558103 250,382 36,400 17.01 17,722 21.94 0.2584
2017-04-19 2017-03-31 13F Gilead Sciences common 375558103 213,982 -15,300 -6.67 14,534 -11.48 0.2284
2017-01-17 2016-12-31 13F Gilead Sciences common 375558103 229,282 3,100 1.37 16,419 -8.25 0.3014
2016-10-28 2016-09-30 13F Gilead Sciences common 375558103 226,182 31,900 16.42 17,896 10.42 0.3520
2016-07-08 2016-06-30 13F Gilead Sciences common 375558103 194,282 -37,000 -16.00 16,207 -23.71 0.3435
2016-04-11 2016-03-31 13F Gilead Sciences common 375558103 231,282 115,300 99.41 21,246 81.02 0.4438
2016-01-20 2015-12-31 13F Gilead Sciences common 375558103 115,982 4,200 3.76 11,736 6.93 0.2516
2015-10-21 2015-09-30 13F Gilead Sciences common 375558103 111,782 0 0.00 10,976 -16.14 0.2741
2015-07-07 2015-06-30 13F Gilead Sciences common 375558103 111,782 -15,100 -11.90 13,087 5.12 0.2885
2015-05-18 2015-03-31 13F Gilead Sciences common 375558103 126,882 46,600 58.05 12,451 64.53 0.2772
2015-05-19 2014-12-31 13F Gilead Sciences common 375558103 80,282 -4,400 -5.20 7,567 -16.05 0.1713
2015-02-17 2014-09-30 13F Gilead Sciences common 375558103 84,682 5,600 7.08 9,014 37.49 0.1984
2014-07-07 2014-06-30 13F Gilead Sciences common 375558103 79,082 8,000 11.25 6,557 22.75 0.1387
2014-01-27 2013-12-31 13F Gilead Sciences common 375558103 71,082 -6,900 -8.85 5,342 9.00 0.1255
2013-10-17 2013-09-30 13F Gilead Sciences common 375558103 77,982 -21,518 -21.63 4,900 -3.83 0.1342
2013-07-31 2013-06-30 13F Gilead Sciences common 375558103 99,500 99,500 5,095 0.1508
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.